In vivo effects of curcumin and deferoxamine in experimental endometriosis
dc.authorid | Ulucam, Enis/0000-0002-4686-7350 | |
dc.authorid | Uz, Yesim/0000-0002-0381-4590 | |
dc.authorwosid | Ulucam, Enis/AAG-9204-2019 | |
dc.authorwosid | Uluçam, Enis/HQZ-3831-2023 | |
dc.authorwosid | Yılmaz, Ali/KLZ-9798-2024 | |
dc.contributor.author | Kizilay, Gulnur | |
dc.contributor.author | Uz, Yesim Hulya | |
dc.contributor.author | Seren, Gulay | |
dc.contributor.author | Ulucam, Enis | |
dc.contributor.author | Yilmaz, Ali | |
dc.contributor.author | Cukur, Ziya | |
dc.contributor.author | Kayisli, Umit Ali | |
dc.date.accessioned | 2024-06-12T10:58:58Z | |
dc.date.available | 2024-06-12T10:58:58Z | |
dc.date.issued | 2017 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Background. Endometriosis is one of the most common chronic gynecological diseases. Objectives. The aim of the study was to examine the effects of curcumin and/or deferoxamine on cell proliferation in a rat model of endometriosis. Material and methods. Thirty female 12-week-old albino Wistar rats, weighing 200-250 g, were used in this study. All the rats underwent ovariectomy and 0.1-mg beta-estradiol 17-valerate pellets were placed intraperitoneally. An experimental model of endometriosis was created in all the animals. To create the experimental model, an approximately 1-cm long section of the uterus was taken, primarily from the right horn of the uterus. Autologous fragments were then placed between the peritoneum and muscle. The animals were divided into 3 groups: Group A, treated only with the vehicle used for curcumin and deferoxamine; group B, treated with curcumin (100 mg/kg body weight); and group C, treated with deferoxamine + curcumin (100 mg/kg body weight). After biopsy samples were obtained, the sections were stained with hematoxylin and eosin. Immunostaining for cytokeratin-7 and proliferating cell nuclear antigen (PCNA) was performed. Blood iron levels were measured using a Perkin Elmer AAnalyst 800 Atomic Absorption Spectrophotometer. Results. The endometrial implant size increased in Group A, but treatment with curcumin (p = 0.01) and deferoxamine + curcumin (p = 0.007) reduced the implant size. In ectopic endometrial epithelial cells, there were significant decreases in PCNA immunoreactivity between groups A and B (p = 0.044) and between groups A and C (p = 0.033). Conclusions. Treatment with curcumin alone and/or in combination with deferoxamine contributed to a reduction in implant size and cell proliferation in a rat endometriosis model. Iron-chelating agents may act in the same manner when used in women with endometriosis; however, further studies from different perspectives are still needed. | en_US |
dc.description.sponsorship | Trakya University Research Center, Edirne, Turkey | en_US |
dc.description.sponsorship | This study was supported by Trakya University Research Center, Edirne, Turkey. | en_US |
dc.identifier.doi | 10.17219/acem/31186 | |
dc.identifier.endpage | 213 | en_US |
dc.identifier.issn | 1899-5276 | |
dc.identifier.issn | 2451-2680 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 28791836 | en_US |
dc.identifier.scopus | 2-s2.0-85018340638 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 207 | en_US |
dc.identifier.uri | https://doi.org/10.17219/acem/31186 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20267 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000402469300003 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wroclaw Medical Univ | en_US |
dc.relation.ispartof | Advances In Clinical And Experimental Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Curcumin | en_US |
dc.subject | Endometriosis | en_US |
dc.subject | Deferoxamine | en_US |
dc.subject | PCNA | en_US |
dc.subject | Iron Overload | en_US |
dc.subject | Lesions | en_US |
dc.subject | Cells | en_US |
dc.subject | Model | en_US |
dc.subject | Vascularization | en_US |
dc.subject | Involvement | en_US |
dc.subject | Growth | en_US |
dc.subject | Rats | en_US |
dc.title | In vivo effects of curcumin and deferoxamine in experimental endometriosis | en_US |
dc.type | Article | en_US |